logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12161674 B1

PDFFull Text
Date of Patent:
Dec. 10, 2024

Filed:

Dec. 05, 2018

Crispr-cas9 modified cd34+ human hematopoietic stem and progenitor cells and uses thereof

Applicant:

Vertex Pharmaceuticals Incorporated, Boston, MA (US);

Inventors:

Ewelina Morawa, Cambridge, MA (US);

Tirtha Chakraborty, Cambridge, MA (US);

Ante Sven Lundberg, Cambridge, MA (US);

Tony Ho, Cambridge, MA (US);

Laura Sandler, Cambridge, MA (US);

Brenda Eustace, Boston, MA (US);

Jerome Rossert, Boston, MA (US);

Robert Kauffman, Boston, MA (US);

Assignee:

Vertex Pharmaceuticals Incorporated, Boston, MA (US);

Attorney:

McNeill PLLC

Primary Examiner:

Allison M Fox

Assistant Examiner:

Jennifer S Spence

Int. Cl.
CPC ...
A61K 35/28 (2015.01); A61K 31/255 (2006.01); A61K 31/395 (2006.01); A61K 35/18 (2015.01); A61K 38/19 (2006.01); A61P 7/00 (2006.01); C12N 5/0789 (2010.01); C12N 9/22 (2006.01); C12N 15/11 (2006.01);
U.S. Cl.
CPC ...
A61K 35/28 (2013.01); A61K 31/255 (2013.01); A61K 31/395 (2013.01); A61K 35/18 (2013.01); A61K 38/193 (2013.01); A61P 7/00 (2018.01); C12N 5/0647 (2013.01); C12N 9/22 (2013.01); C12N 15/11 (2013.01); C12N 2310/20 (2017.05); C12N 2310/315 (2013.01); C12N 2310/321 (2013.01);
Abstract

Provided herein, in some embodiments, are methods and compositions for treatment of subjects with β-thalassemia and subjects with severe sickle cell disease using autologous CRISPR-Cas9 modified CD34+ human hematopoietic stem and progenitor cells.

Find Patent Forward Citations

Morawa, Ewelina. (2024). Crispr-cas9 modified cd34+ human hematopoietic stem and progenitor cells and uses thereof (U.S. Patent No. 12161674). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12161674

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…